About: http://webisa.webdatacommons.org/210280151

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	All my opinion but pimavanserin shares a market with no other drugs in its class...it owns the entire potential market for this particular class of agent in Parkinson's, Alzheimer's, schiz and other indications.
http://www.w3.org/ns/prov#wasQuotedFrom	yahoo.com